Stay updated on SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.

Latest updates to the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a new Study Status section (revision 123) on 2026-03-23 to show the current recruitment/status, with a prior item removed on 2026-02-02.SummaryDifference0.1%

- Check16 days agoChange DetectedThe history now includes revision v3.5.0 and removes v3.4.3. This is a page revision update and does not modify the study data or main content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.4.3 has been added to the page history, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check52 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed from the list.SummaryDifference0.0%

- Check59 days agoChange DetectedNew revision entry v3.4.1 appears in the version history, and a 'Study Status' section is listed under additions. The previous revision v3.4.0 is shown as a deletion.SummaryDifference0.2%

- Check67 days agoChange DetectedNew UI elements include Show glossary and Hide glossary options and a legend for green highlights (additions) and red highlights (deletions), plus a color-coded note explaining changes. The revision label now reads Revision: v3.4.0, replacing v3.3.4.SummaryDifference0.4%

Stay in the know with updates to SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.